Reference record for OID 2.16.840.1.113883.11.21026

Parent
2.16.840.1.113883.11 (valueSets)
Node code
21026
Node names
  • AdverseEventCRSerCrit
  • adverse-event-clinical-research-seriousness-criteria
Numeric OID
2.16.840.1.113883.11.21026
URN notation
urn:oid:2.16.840.1.113883.11.21026
ASN.1 notation

{2 16 840 1 113883 11 21026}

  • {joint-iso-itu-t(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-itu-t(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
OID-IRI notation
  • /2/16/840/1/113883/11/21026
  • /Country/840/1/113883/11/21026
  • /Joint-ISO-ITU-T/16/840/1/113883/11/21026
Named path variants
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria

Descriptions

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria — HL7 Terminology

Action criteria usually associated with serious events that pose a threat to a patient's life or functioning. Adverse Events criteria to expand on the seriousness of the adverse event. Typically used in reporting for Clinical Research, post-market surveillance (e.g. Form FDA 3500A MedWatch). The adverse event seriousness criteria value set is based on the ICH E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting guidance (https://database.ich.org/sites/default/files/E2D_Guideline.pdf). For information on ICH see https://admin.ich.org/sites/default/files/inline-files/OID_Information_Paper_1.pdf from the INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) document ICH E2B(R3), the Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide Data Elements and Message Specification, and ICH M8, the Electronic Common Technical Document

Source records

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Status in source: active.

Names: AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Technical details
{
  "url": "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-seriousness-criteria",
  "date": "2023-07-28T19:27:19+00:00",
  "title": "Adverse Event Clinical Research Seriousness Criteria",
  "status": "active",
  "contact": [
    {
      "telecom": [
        {
          "value": "http://hl7.org",
          "system": "url"
        },
        {
          "value": "hq@HL7.org",
          "system": "email"
        }
      ]
    }
  ],
  "version": "1.0.0",
  "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "publisher": "Health Level Seven International",
  "experimental": false,
  "resource_type": "ValueSet",
  "oid_identifier": {
    "value": "urn:oid:2.16.840.1.113883.11.21026",
    "system": "urn:ietf:rfc:3986"
  }
}

First Registration Authority (inferred from ancestor 2.16.840.1.113883)

W. Ted Klein

Current Registration Authority (inferred from ancestor 2.16.840.1)

Karen Hughes

Siblings (1453)

OIDNameDirect childrenDescendantsDescription
2.16.840.1.113883.11.21044 HL7_Affiliate, hl7-affiliate00
2.16.840.1.113883.11.21045 HL7_Staff_Role, hl7-staff-role00
2.16.840.1.113883.11.21046 HL7_JIRA_SPEC_WORK_GROUP, hl7-jira-spec-work-group00